Related Experiment Video
Updated: Aug 17, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis
Oscar A Bizzozero1, Gisela DeJesus, Kelly Callahan
1Department of Cell Biology and Physiology, University of New Mexico-Health Sciences Center, Albuquerque, New Mexico 87131-5218, USA. obizzozero@salud.unm.edu
Abstract:
Oxidative stress has been implicated in the pathophysiology of multiple sclerosis (MS). Increased levels of reactive oxygen species (ROS) derived from infiltrating macrophages and microglial cells have been shown to reduce the levels of endogenous antioxidants and to cause the oxidation of various substrates within the MS plaque. To determine whether oxidative damage takes place beyond visible MS plaques, the occurrence of total carbonyls (TCOs) and protein carbonyls (PCOs) in the normal-appearing white matter (NAWM) and gray matter (NAGM) of eight MS brains was assessed and compared with those of four control brains. The data show that most (7/8) of the MS-WM samples contain increased amounts of PCOs as determined by reaction with 2,4-dinitrophenylhydrazine and Western blot analysis. These samples also have high levels of glial fibrilary acidic protein (GFAP), suggesting that oxidative damage is related to the presence of small lesions. In contrast, we detected no evidence of protein thiolation (glutathionylation and cysteinylation) in the diseased tissue. To our surprise, MS-NAGM specimens with high GFAP content also showed three times the concentration of TCOs and PCOs as the controls. The increase in PCOs is likely to be a consequence of reduced levels of antioxidants, in that the concentration of nonprotein thiols in both MS-WM and -GM decreased by 30%. Overall, our data support the current view that both NAWM and -GM from MS brains contain considerable biochemical alterations. The involvement of GM in MS was also supported by the decrease in the levels of neurofilament light protein in all the specimens analyzed. To the best of our knowledge, this is the first study demonstrating the presence of increased protein carbonylation in post-mortem WM and GM tissue of MS patients.
Insights
Oxidative damage, indicated by increased protein carbonyls (PCOs), occurs in normal-appearing white and gray matter of multiple sclerosis (MS) brains, suggesting widespread biochemical alterations beyond visible lesions.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Oxidative stress is a key factor in multiple sclerosis (MS) pathophysiology.
- Reactive oxygen species (ROS) from immune cells contribute to substrate oxidation within MS plaques.
- The extent of oxidative damage in normal-appearing brain tissue in MS is not fully understood.
Purpose of the Study:
- To investigate oxidative damage in normal-appearing white matter (NAWM) and normal-appearing gray matter (NAGM) of MS brains.
- To quantify total carbonyls (TCOs) and protein carbonyls (PCOs) in MS brain tissue.
- To assess the relationship between oxidative damage markers and other biochemical alterations in MS.
Main Methods:
- Analysis of TCOs and PCOs in post-mortem brain tissue from MS patients and controls.
- Western blot analysis using 2,4-dinitrophenylhydrazine to detect PCOs.
- Measurement of glial fibrillary acidic protein (GFAP) and nonprotein thiols.
Main Results:
- Increased PCOs were found in most MS white matter samples (7/8), correlating with higher GFAP levels.
- MS gray matter also exhibited significantly elevated TCOs and PCOs (threefold increase) compared to controls.
- A 30% decrease in nonprotein thiols was observed in both MS white and gray matter, indicating reduced antioxidant capacity.
Conclusions:
- Biochemical alterations, including oxidative damage, are present in both NAWM and NAGM of MS brains.
- Increased protein carbonylation in seemingly normal brain tissue suggests widespread oxidative stress in MS.
- Findings support the involvement of gray matter in MS pathology and highlight the need for therapies targeting oxidative stress.
Related Concept Videos
Multiple Sclerosis l: Introduction
Neural Regulation

